These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1966923)

  • 1. Cytomegalovirus and other herpesviruses infections in heart and bone marrow transplant recipients.
    Weinberg A; Boas LS; Feher O; Strabelli TM; Fink MC; Dulley FL; Uip DE; Bellotti G; Chamone DA; Amato Neto V
    Rev Inst Med Trop Sao Paulo; 1990; 32(5):338-45. PubMed ID: 1966923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
    Tan HH; Goh CL
    Am J Clin Dermatol; 2006; 7(1):13-29. PubMed ID: 16489840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies.
    Singh N; Dummer JS; Kusne S; Breinig MK; Armstrong JA; Makowka L; Starzl TE; Ho M
    J Infect Dis; 1988 Jul; 158(1):124-31. PubMed ID: 2839576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
    Ormrod D; Scott LJ; Perry CM
    Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention and therapy of herpesvirus infections].
    Abb J
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acyclovir prophylaxis in bone marrow transplant recipients.
    Lundgren G; Wilczek H; Lönnqvist B; Lindholm A; Wahren B; Ringdén O
    Scand J Infect Dis Suppl; 1985; 47():137-44. PubMed ID: 3006228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation.
    Burns LJ; Miller W; Kandaswamy C; DeFor TE; MacMillan ML; Van Burik JA; Weisdorf DJ
    Bone Marrow Transplant; 2002 Dec; 30(12):945-51. PubMed ID: 12476289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serologic follow-up of cytomegalovirus, herpes simplex and varicella-zoster infections in kidney transplant recipients].
    Merlino C
    G Batteriol Virol Immunol; 1991; 84(1-12):41-52. PubMed ID: 1668971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of cytomegalovirus in donors & opportunistic viral infections in liver transplant recipients.
    Varghese J; Subramanian S; Reddy MS; Shanmugam N; Balajee G; Srinivasan V; Venkataraman J; Mohamed R
    Indian J Med Res; 2017 Apr; 145(4):558-562. PubMed ID: 28862190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and impact of herpes simplex and cytomegalovirus detection in the respiratory tract after lung transplantation.
    Engelmann I; Hesse N; Fegbeutel C; Strüber M; Wehrhane M; Gottlieb J; Welte T; Schulz TF; Simon AR; Mattner F
    Transpl Infect Dis; 2011 Jun; 13(3):259-65. PubMed ID: 21156011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral infections in leukemia and bone marrow transplant patients.
    Wingard JR
    Leuk Lymphoma; 1993; 11 Suppl 2():115-25. PubMed ID: 8124223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of acyclovir for prophylaxis of herpes infections in severely immunocompromised patients.
    Prentice HG
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():153-9. PubMed ID: 6313594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Reusser P; Cordonnier C; Einsele H; Engelhard D; Link D; Locasciulli A; Ljungman P
    Bone Marrow Transplant; 1996 May; 17(5):813-7. PubMed ID: 8733703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation.
    Goodrich JM; Mori M; Gleaves CA; Du Mond C; Cays M; Ebeling DF; Buhles WC; DeArmond B; Meyers JD
    N Engl J Med; 1991 Dec; 325(23):1601-7. PubMed ID: 1658652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpesviruses excretion in saliva of pediatric transplant recipients.
    Correa Sierra CB; Kourí Cardellá V; Pérez Santos L; Silverio CE; Hondal N; Florin J
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28834054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
    Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular immunity to vaccinations and herpesvirus infections after bone marrow transplantation.
    Gratama JW; Verdonck LF; van der Linden JA; van Heugten JG; Kreeft HA; D'Amaro J; Zwaan FE; de Gast GC
    Transplantation; 1986 Jun; 41(6):719-24. PubMed ID: 3012833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts.
    Erice A; Jordan MC; Chace BA; Fletcher C; Chinnock BJ; Balfour HH
    JAMA; 1987 Jun; 257(22):3082-7. PubMed ID: 3035246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic ganciclovir is more effective in HLA-identical family member marrow transplant recipients than in more heavily immune-suppressed HLA-identical unrelated donor marrow transplant recipients. Australasian Bone Marrow Transplant Study Group.
    Atkinson K; Arthur C; Bradstock K; Dale B; Downs K; Gibson J; Golenia M; Ho J; Joshua D; Juttner C
    Bone Marrow Transplant; 1995 Sep; 16(3):401-5. PubMed ID: 8535313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis against herpesvirus infections in transplant recipients.
    Ljungman P
    Drugs; 2001; 61(2):187-96. PubMed ID: 11270937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.